Cardiovascular risk awareness, treatment, and control in urban Latin America

Honorio Silva1, Rafael Hernandez-Hernandez, Raul Vinueza

  • 1Project Globe Consortium for Continued Professional Development, New York, NY 10017, USA. honorio.silva@globecpd.org

Insights

Cardiovascular disease prevention in Latin America needs improvement. Many individuals with hypertension, diabetes, and hypercholesterolemia remain undiagnosed or untreated, highlighting a critical need for better screening and adherence.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular diseases (CVDs) necessitate regular screening for risk factors, high awareness, effective treatment, and patient adherence.
  • The Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study assessed major CVD risk factors across seven Latin American cities.

Purpose of the Study:

  • To present data on the assessment, diagnosis, prevalence, treatment effectiveness, and adherence to treatment for major cardiovascular risk factors in Latin America.
  • To identify reasons for nonadherence to treatment among the study population.

Main Methods:

  • A cross-sectional, population-based, observational study involving 5383 men and 6167 women aged 25-64.
  • Data collection included household questionnaire-based interviews and clinic visits for anthropometric and laboratory assessments.
  • Study sites included Barquisimeto, Bogota, Buenos Aires, Lima, Mexico City, Quito, and Santiago.

Main Results:

  • High rates of prior diagnosis for hypertension (64%) and diabetes (78%), but low for hypercholesterolemia (41%).
  • A majority of affected individuals were untreated: 88% for hypercholesterolemia, 67% for diabetes, and 53% for hypertension.
  • Treatment control targets were achieved by 51% for hypertension, 16% for diabetes, and 52% for hypercholesterolemia.
  • Treatment adherence was 69% for hypertension, 63% for diabetes, and 66% for hypercholesterolemia, with forgetfulness being the primary reason for nonadherence.

Conclusions:

  • Significant gaps exist in the diagnosis, treatment, and control of cardiovascular risk factors in the studied Latin American cities.
  • There is a substantial need to enhance patient education, screening, treatment initiation, and adherence to manage cardiovascular risk factors effectively.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...